Interestingly, significantly increased expression of M2 markers of CD163, CD206 and p-STAT6/STAT6 ratio and slightly increased expression of Arg-1 were found in NASH patients as well. Here, CD163 is linked to metabolic dysfunction-associated steatohepatitis.